Bionx Medical Makes Reimbursement Case For Bionic Ankle
This article was originally published in Clinica
BionX Medical is working to secure US Medicare coverage for its BioM powered ankle prosthesis with the goal of either becoming an attractive acquisition target or a stronger investment proposition for an initial public offering, CEO Charles Carignan told Clinica.
You may also be interested in...
The FAST 01 feasibility trial is evaluating a modification to Varian’s ProBeam particle accelerator that enables ultra-high dose radiation to treat cancer.
Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.
In this week’s podcast, Marion Webb reviews her interview with Glooko CEO Russ Johannesson and Reed Miller explains how Boston Scientific is restructuring its transcatheter aortic valve business.